Molecular Oncology of Lung Cancer! Radiation Oncologist Perspective!!

Major Dr MQ Baig

Abstract: Lung cancer is the leading cause of cancer related death worldwide and Indian population based cancer registry data fully complementing to that, lung cancer histological as well as molecularly is highly heterogeneous disease, previous WHO classification needed to modified by WHO in view of that revised WHO classification based on Immunohistochemistry markers taken up into consideration for lung cancer treatment, prognosis as well as its prediction in this review article will explore all the molecular subtypes of lung cancer along briefly about its specific targeted drugs.

Keywords: Immunohistochemistry, Targeted drugs, Lung cancer

How to Cite?: Major Dr MQ Baig, "Molecular Oncology of Lung Cancer! Radiation Oncologist Perspective!!", Volume 11 Issue 5, May 2022, International Journal of Science and Research (IJSR), Pages: 1842-1844, https://www.ijsr.net/getabstract.php?paperid=MR22526115610, DOI: https://dx.doi.org/10.21275/MR22526115610